Jason A Hoppe1, Howard Kim2, Kennon Heard3. 1. Department of Emergency Medicine, University of Colorado Denver School of Medicine, Aurora, CO; Rocky Mountain Poison and Drug Center, Denver, CO. Electronic address: jason.hoppe@ucdenver.edu. 2. Department of Emergency Medicine, University of Colorado Denver School of Medicine, Aurora, CO; Denver Health Residency in Emergency Medicine, Denver, CO. 3. Department of Emergency Medicine, University of Colorado Denver School of Medicine, Aurora, CO; Rocky Mountain Poison and Drug Center, Denver, CO.
Abstract
STUDY OBJECTIVE: Acute pain complaints are commonly treated in the emergency department (ED). Short courses of opioids are presumed to be safe for acute pain; however, the risk of recurrent opioid use after receipt of an ED opioid prescription is unknown. We describe the risk of recurrent opioid use in patients receiving an opioid prescription from the ED for an acute painful condition. METHODS: This is a retrospective cohort study of all patients discharged from an urban academic ED with an acute painful condition during a 5-month period. Clinical information was linked to data from Colorado's prescription drug monitoring program. We compared opioid-naive patients (no opioid prescription during the year before the visit) who filled an opioid prescription or received a prescription but did not fill it to those who did not receive a prescription. The primary outcome was the rate of recurrent opioid use, defined as filling an opioid prescription within 60 days before or after the first anniversary of the ED visit. RESULTS: Four thousand eight hundred one patients were treated for an acute painful condition; of these, 52% were opioid naive and 48% received an opioid prescription. Among all opioid-naive patients, 775 (31%) received and filled an opioid prescription, and 299 (12%) went on to recurrent use. For opioid-naive patients who filled a prescription compared with those who did not receive a prescription, the adjusted odds ratio for recurrent use was 1.8 (95% confidence interval 1.3 to 2.3). For opioid-naive patients who received a prescription but did not fill it compared with those who did not receive a prescription, the adjusted odds ratio for recurrent use was 0.8 (95% confidence interval 0.5 to 1.3). CONCLUSION: Opioid-naive ED patients prescribed opioids for acute pain are at increased risk for additional opioid use at 1 year.
STUDY OBJECTIVE: Acute pain complaints are commonly treated in the emergency department (ED). Short courses of opioids are presumed to be safe for acute pain; however, the risk of recurrent opioid use after receipt of an ED opioid prescription is unknown. We describe the risk of recurrent opioid use in patients receiving an opioid prescription from the ED for an acute painful condition. METHODS: This is a retrospective cohort study of all patients discharged from an urban academic ED with an acute painful condition during a 5-month period. Clinical information was linked to data from Colorado's prescription drug monitoring program. We compared opioid-naive patients (no opioid prescription during the year before the visit) who filled an opioid prescription or received a prescription but did not fill it to those who did not receive a prescription. The primary outcome was the rate of recurrent opioid use, defined as filling an opioid prescription within 60 days before or after the first anniversary of the ED visit. RESULTS: Four thousand eight hundred one patients were treated for an acute painful condition; of these, 52% were opioid naive and 48% received an opioid prescription. Among all opioid-naive patients, 775 (31%) received and filled an opioid prescription, and 299 (12%) went on to recurrent use. For opioid-naive patients who filled a prescription compared with those who did not receive a prescription, the adjusted odds ratio for recurrent use was 1.8 (95% confidence interval 1.3 to 2.3). For opioid-naive patients who received a prescription but did not fill it compared with those who did not receive a prescription, the adjusted odds ratio for recurrent use was 0.8 (95% confidence interval 0.5 to 1.3). CONCLUSION: Opioid-naive ED patients prescribed opioids for acute pain are at increased risk for additional opioid use at 1 year.
Authors: Matthew J Witry; Barbara J St Marie; Brahmendra Reddy Viyyuri; Paul D Windschitl Journal: Pain Manag Nurs Date: 2019-05-24 Impact factor: 1.929
Authors: Zachary F Meisel; Nicoleta Lupulescu-Mann; Christina J Charlesworth; Hyunjee Kim; Benjamin C Sun Journal: Ann Emerg Med Date: 2019-06-20 Impact factor: 5.721
Authors: Adam S Reinstein; Lauren O Erickson; Kristen H Griffin; Rachael L Rivard; Christopher E Kapsner; Michael D Finch; Jeffery A Dusek Journal: Pain Med Date: 2017-01-30 Impact factor: 3.750
Authors: Lauren K Whiteside; Joan Russo; Jin Wang; Megan L Ranney; Victoria Neam; Douglas F Zatzick Journal: J Adolesc Health Date: 2015-10-23 Impact factor: 5.012
Authors: Christopher Griggs; Stephen Wyatt; Meghan K Wally; Michael Runyon; Joseph R Hsu; Rachel B Seymour; Michael Beuhler; Michael J Bosse; Ryan Fogg; Michael Gibbs; Eric Haas; Steven Jarrett; Daniel Leas; Animita Saha; Sharon Schiro; Bradley Watling Journal: J Addict Med Date: 2019 Sep/Oct Impact factor: 3.702
Authors: Michael J Ward; Diwas Kc; Cathy A Jenkins; Dandan Liu; Amit Padaki; Jesse M Pines Journal: Am J Emerg Med Date: 2018-07-31 Impact factor: 2.469